EverHint Signal — Momentum Swing: Aggressive Momentum — January 05, 2026

What This Signal Is (Quick)

The Aggressive Momentum strategy identifies stocks experiencing a triple threat: high momentum + high volume + high volatility. These are breakout candidates with explosive potential—but with correspondingly high risk.

Signal Requirements:

• Volume Thrust: 2.0x+ average daily volume—institutional money is moving in
• Volatility: 50%+ annualized volatility—large price swings expected
• Strong Momentum: Positive rate of change across multiple timeframes (10, 21, 63 days)
• Near 52-Week Highs: Typically trading at 95%+ of 52-week high—strength begets strength

Why This Matters: High volume confirms institutional participation, not just retail hype. High volatility means big moves—both up and down. When momentum stocks trade near highs with expanding volume, they're either about to break out further or exhaust. This scanner catches them at the critical inflection point.

Best For: Aggressive swing traders with 1-4 week holding periods who can tolerate 10-20% intraday swings and have tight risk management discipline. Not for conservative investors.

This is an experimental scanner. Signals are for educational purposes and back-testing only. Always do your own due diligence.

How We Ranked Today (Reader Version)

We ranked signals by composite score (0-100 scale), which combines momentum strength, volume quality, relative strength vs. SPY, and price position vs. moving averages. Higher scores indicate higher-quality breakout setups with better risk/reward characteristics.

We've overlaid three additional data points for context:

• Vol Thrust: Volume multiplier vs. 20-day average. 2.5x means today's volume was 2.5 times the 20-day average—strong institutional participation.
• % of 52W High: How close the stock is to its 52-week high. 100% means AT the high. Stocks near highs show persistent strength.
• Insider Net (USD): Net insider buying or selling over the last 90 days. Only open-market purchases (P) and sales (S) count. Insider selling on high-momentum names is common (taking profits) but heavy selling can be a red flag.
• Days → Earnings: How many days until the next earnings report. Momentum stocks often accelerate into earnings.

Today we scanned 8 aggressive momentum signals—a highly selective list representing the most explosive setups in the market.

🔥 Breakout Signals

These stocks triggered aggressive momentum breakouts on January 5, 2026—high volume, high volatility, strong momentum.

Field Notes:

Understanding the Metrics:

• Score (0-100): FOLD leads with 90, VICR at 87, DVAX at 76—these are the highest-quality setups. GMED at 0 is the weakest technically despite making the scan (likely just crossed threshold).

• Vol Thrust: VICR shows explosive 4.34x volume—massive institutional interest. QXO (3.55x) and FTAI (3.09x) also show strong participation. Even the "weakest" (FOLD at 2.06x) is still double normal volume.

• % of 52-Week High: 7 of 8 signals are AT their 52-week high (100.0%). FOLD at 99.9% and GMED at 99.2% are barely off highs. This is extreme strength—momentum begets momentum, but also increases exhaustion risk.

• Volatility Context: All signals meet the 50%+ annualized volatility threshold. VICR (79%), DVAX (70%), HROW (63%), GMED (67%) show the highest volatility—expect large daily swings.

Sector Patterns:
Healthcare dominated with 4 of 8 signals (FOLD, DVAX, HROW, GMED), suggesting strong sector momentum. Technology had 3 (VICR, NVMI, QXO), Industrials 1 (FTAI).

Insider Activity - Key Red Flag:

• Heavy Selling: GMED (-$2.34M from CFO Kyle Kline selling 18,542 shares at $90), FOLD (-$1.52M from multiple executives including CEO, CLO, CDO), VICR (-$248K from VP-level officers)
• No Insider Buying: Zero signals show insider purchases in the last 90 days
• Interpretation: Insiders are taking profits on high-momentum names. This is not unusual for volatile stocks near highs, but the absence of ANY buying is notable. Trade with caution.

Earnings Proximity:

• Near-term (< 45 days): NVMI (38 days), FOLD (44 days), VICR (44 days), DVAX (45 days), GMED (45 days)
• Mid-term (45-60 days): FTAI (51 days), QXO (57 days)
• Distant: HROW (80 days)
• Note: 5 of 8 signals report earnings within 45 days—momentum may be earnings-related. Increased volatility into earnings.

Relative Strength vs. SPY:
All signals show positive RS_21 (relative strength vs. SPY over 21 days), meaning they outperformed the broad market. FOLD (45%), VICR (45%), DVAX (40%), HROW (35%), FTAI (33%) lead—significantly stronger than S&P 500.

Price vs. Moving Averages:
All signals trade well above their 10, 21, 50, and 200-day moving averages—confirming strong uptrends across all timeframes. No mean reversion setups here—these are pure momentum plays.

Recent Headlines

Note: Limited recent news coverage for these specific tickers. Most are small/mid-cap names with lower media attention. Momentum appears technically driven rather than news-driven.

What We Found:

• FOLD - Amicus Therapeutics: Rare disease biotech focused on Fabry and Pompe diseases. No major recent headlines. Stock up 73% over 63 days (r63 = 0.73).

• VICR - Vicor Corporation: Power component manufacturer. Stock up 173% over 63 days (r63 = 1.73)—strongest performer in the group. No major catalysts—likely technical breakout driving momentum.

• DVAX - Dynavax Technologies: Vaccine and immunotherapy company. Stock up 50% over 63 days. No significant news events.

• FTAI - FTAI Aviation: Aviation leasing and maintenance company. Strong industrials sector momentum. Up 31% over 63 days.

• HROW - Harrow Health: Ophthalmic pharmaceutical company. Up 15% over 63 days. Lower momentum than peers but met volume/volatility thresholds.

• NVMI - Nova Ltd.: Semiconductor process control equipment. Trading at all-time highs. Up 16% over 63 days.

• QXO - QXO, Inc.: Business services and distribution (Brad Jacobs company). Up 17% over 63 days. Recent IPO/SPAC momentum.

• GMED - Globus Medical: Medical device company (spine/orthopedics). Up 56% over 63 days. Also appeared on EMA10 × Price × MACD signal today—dual confirmation from multiple strategies.

Key Observation: The absence of major news catalysts suggests these are technically-driven momentum plays rather than fundamental breakouts. Traders are chasing price action, not stories. This increases the risk of sharp reversals when momentum fades.

Vlad's Take (EverHint)

Market Context: S&P 500 closed +0.14% at 6,902, Nasdaq -0.23% at 23,396, Dow +1.09% at 48,977 on January 5th. Mixed sentiment with defensive rotation—Dow leading, Nasdaq lagging slightly. VIX at 14.9, just below the 15 threshold, indicating low-to-normal volatility. Small-caps outperformed (Russell 2000 +1.24%), showing some market breadth. Crypto rallied: Bitcoin +2.77% to $94K, Ethereum +3.07%. Overall: Cautiously constructive environment with decent breadth, but VIX creeping higher suggests some underlying tension.

On These Signals: Only 8 aggressive momentum signals triggered today—that's a highly selective list, which is actually bullish for signal quality. The Aggressive Momentum strategy has strict thresholds (2.0x volume, 50%+ volatility, strong momentum), so when signals fire, they're worth paying attention to.

The Extreme Positioning: 7 of 8 signals are AT their 52-week high (100.0%). That's not just strength—that's parabolic. Stocks don't stay at all-time highs forever. The question: Are these breaking out to new legs higher, or exhausting? With VIX at 14.9 (low complacency), there's room for momentum to continue short-term, but risk of sharp reversals is elevated.

Healthcare Sector Momentum: 4 of 8 signals from Healthcare (FOLD, DVAX, HROW, GMED) suggests strong sector rotation. This aligns with the Dip & Bounce strategy also showing heavy Healthcare representation today—sector is volatile but attracting capital. FOLD, DVAX, and GMED are all biotech—high-risk, high-reward plays sensitive to clinical trial data and FDA approvals.

The Standouts:

1. FOLD (Amicus Therapeutics) - Score 90, Top Pick

• Highest composite score (90), meaning best risk/reward setup
• Up 73% over 63 days—strong but not parabolic like VICR
• Volume 2.06x (lowest in group, but still 2x normal)
• Red Flag: Heavy insider selling (-$1.52M from CEO, CLO, CDO in Nov-Dec)
• 99.9% of 52-week high—essentially at highs
• Earnings in 44 days—moderate catalyst risk
• Play: If entering, watch for pullback to $13.50 (near MA10 at $14.24). Don't chase at all-time highs. Target $15.50-$16.00 (next resistance).

2. VICR (Vicor Corporation) - Score 87, High-Risk/High-Reward

• 4.34x volume thrust—absolutely explosive
• Up 173% over 63 days—this is EXTREME momentum, likely unsustainable
• 79% annualized volatility—expect $10-15 daily swings
• Red Flag: Insider selling (-$248K), but smaller amount than FOLD
• AT 52-week high (100.0%)
• Risk: This is the definition of "overbought." Could go to $150+ or crash to $115 in a day. Only for aggressive momentum traders with tight stops.
• Play: If entering, set stop at $125 (recent consolidation). Target $145-150. Hold time: Days, not weeks.

3. DVAX (Dynavax) - Score 76, Biotech Lottery

• Clean setup—no insider selling
• 100% at 52-week high, 2.17x volume
• Up 50% over 63 days—strong but not absurd
• 70% volatility—big swings expected
• Play: More fundamentals-driven than VICR. Watch for pullback to $14.50. Earnings in 45 days could be catalyst.

4. FTAI (FTAI Aviation) - Score 61, Institutional Favorite

• Largest market cap ($23.2B)—more liquidity, lower risk than small-caps
• 3.09x volume—strong institutional participation
• Up 31% over 63 days—healthy momentum, not parabolic
• Industrials sector—benefiting from aviation recovery theme
• Play: Most "investable" of the group. Less risky than biotech lottery tickets. Consider small position if rotation into cyclicals continues.

5-8. Lower Scores (HROW, NVMI, QXO, GMED):

• HROW: Score 43, distant earnings (80 days), weakest momentum (r63 = 15%)
• NVMI: Score 29, semiconductor play, earnings in 38 days
• QXO: Score 14, Brad Jacobs SPAC, speculative
• GMED: Score 0, heavy insider selling (-$2.34M), also on EMA10 signal—dual confirmation but insiders dumping is red flag

The Insider Selling Problem: ZERO signals show insider buying. All insider activity is selling (FOLD, VICR, GMED). When insiders are unloading stock at all-time highs while volume is exploding, it's a yellow flag. They may know something, or they may just be taking profits. Either way, it's not bullish.

Trading This Strategy:

Entry Strategy:

1. Don't chase at all-time highs - Wait for 1-3% pullback intraday or next day
2. Scale in - Start with 1-2% portfolio position, add on strength
3. Use stops religiously - Set mental or hard stops 5-7% below entry. These stocks can gap down 10% overnight.

Position Sizing:

• Max 2-3% per signal (these are HIGH RISK)
• Total aggressive momentum exposure: Max 10% of portfolio
• Use options (call spreads) if you want leveraged exposure with defined risk

Hold Time:

• Target: 1-4 weeks (swing trade)
• Reality: May only hold 3-7 days if momentum fades
• Don't marry these names—they're momentum plays, not investments

Exit Strategy:

• Take profits aggressively - If you're up 10-15% in days, take half off
• Trailing stops - Once up 10%+, trail stop to breakeven
• Volatility management - If daily range expands to 10%+ and you're not up big, exit. Volatility expansion often precedes reversals.
• Volume confirmation - If volume dries up (drops below 1.0x average) on subsequent days, exit. Momentum needs fuel.

Red Flags to Exit Immediately:

1. Break below MA10 on heavy volume
2. Volume dries up (<1.0x average) for 2+ consecutive days
3. VIX spikes above 20 (market-wide risk-off)
4. Negative earnings guidance or FDA rejection (for biotech names)

Risk Warning: These are NOT buy-and-hold stocks. They're high-octane momentum trades. VICR's 173% gain in 63 days can reverse in a week. FOLD's 73% gain can evaporate if a clinical trial disappoints. Trade with strict discipline, tight stops, and position sizing appropriate to your risk tolerance.

Best Approach for Most Traders: Watch these names but don't trade them unless you have experience with high-volatility momentum plays. If you must trade, start with FTAI (largest, most liquid, least volatile) or wait for FOLD to pull back to $13.50. Avoid VICR unless you're a day trader—173% in 63 days is not sustainable.

Support the Channel

🔥 A simple like, share, or subscribe helps this channel reach more traders who follow data, not noise.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/